Add Your Blog | | Signup

NEW DRUG APPROVALS New Drug Approvals all you want to know about drugs

http://newdrugapprovals.wordpress.com/
NEW DRUG APPROVALS · 10h ago

SEN 826

SEN 826 CAS 1160833-51-1 C25 H31 N5 O, 417.55 Methanone, [1-[3-(1-methyl-1H-benzimidazol-2-yl)phenyl]-4-piperidinyl](4-methyl-1-piperazinyl)- CAS HBr SALT 1612250-71-1 WO2009074300 product p...
NEW DRUG APPROVALS · 16h ago

FDA approves first treatment Bavencio (avelumab)for rare form of skin cancer

FDA approves first treatment for rare form of skin cancer 03/23/2017 The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adul...
NEW DRUG APPROVALS · 2d ago

FDA approves drug Xadago (Safinamide, сафинамид , سافيناميد , 沙非胺 , ) to treat Parkinson’s disease

Safinamide Molecular Formula C17H19FN2O2 Average mass 302.343 Da (2S)-2-[[[4-[(3-Fluorophenyl)methoxy]phenyl]methyl]amino]propanamide 133865-89-1 , сафинамид , سافيناميد ,  沙非胺 ,  EMD-119568...
NEW DRUG APPROVALS · 4d ago

New paper on Trelagliptin succinate

Trelagliptin succinate, a novel once-weekly oral dipeptidyl peptidase-4 (DPP-4) inhibitor, was approved for the Japanese market on March 26, 2015 Trelagliptin exhibited a better potency agai...
NEW DRUG APPROVALS · 6d ago

NEW DRUG APPROVALS BLOG HITS 16 LAKH VIEWS IN 213 COUNTRIES

NEW DRUG APPROVALS BLOG HITS 16 LAKH VIEWS IN 213 COUNTRIESFiled under: BLOGS, Uncategorized Tagged: BLOG, New drug approvals
NEW DRUG APPROVALS · 1W ago

Novartis Kisqali® (ribociclib, LEE011) receives FDA approval as first-line treatment for HR+/HER2- metastatic breast cancer in combination with any aromatase inhibitor

Approved based on a first-line Phase III trial that met its primary endpoint of progression-free survival (PFS) at interim analysis due to superior efficacy compared to letrozole alone[1] At...
NEW DRUG APPROVALS · 2W ago

GDC 0994, Ravoxertinib

GDC 0994 GDC-0994; Ravoxertinib; 1453848-26-4; GDC0994; UNII-R6AXV96CRH; R6AXV96CRH, RG7842; RG-7842; RG 7842 CAS 1453848-26-4 1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-me...
NEW DRUG APPROVALS · 2W ago

TROXACITABINE троксацитабин , تروكساسيتابين , 曲沙他滨 ,

Troxacitabine CAS 145918-75-8 Molecular FormulaC8H11N3O4 Average mass213.191 Da троксацитабин تروكساسيتابين 曲沙他滨 2(1H)-Pyrimidinone, 4-amino-1-[(2S,4S)-2-(hydroxymethyl)-1,3-dioxolan-4-yl]- ...
NEW DRUG APPROVALS · 2W ago

Astellas Pharma Inc. new Glucokinase Activator, ASP ? for Type 2 Diabetes

ASP ? (2R)-2-(4-cyclopropanesulfonyl-3-cyclopropylphenyl)-N-[5-(hydroxymethyl)pyrazin-2-yl]-3-[(R)-3-oxocyclopentyl]propanamide CAS 1174229-89-0 MW C25 H29 N3 O5 S Benzeneacetamide, 3-cyclop...
NEW DRUG APPROVALS · 2W ago

FDA approves first treatment Noctiva (Desmopressin acetate) nasal spray for frequent urination at night due to overproduction of urine

Desmopressin acetate FDA approves first treatment for frequent urination at night due to overproduction of urine 03/03/2017 The U.S. Food and Drug Administration today approved Noctiva (desm...